Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Sep;34(9):1647-1652.
doi: 10.1007/s00198-023-06749-z. Epub 2023 Apr 28.

Reducing diagnostic delay in hypophosphatasia: a case series of 14 patients presenting to general rheumatology

Affiliations

Reducing diagnostic delay in hypophosphatasia: a case series of 14 patients presenting to general rheumatology

Muhammad A Rauf et al. Osteoporos Int. 2023 Sep.

Abstract

Objectives: Hypophosphatasia (HPP) is a rare genetic metabolic bone disease that can cause chronic pain and fractures. Its hallmark is a persistently low serum ALP. HPP is now recognised by many osteoporosis specialists, but other specialists, such as rheumatologists and primary care physicians, may be less aware of this condition, causing diagnostic delay and possible harm to these patients. Our objective was to highlight features that can reduce this delay.

Methods: We retrospectively analysed 14 patients that presented with musculoskeletal pain to general rheumatology clinic at St. George's Hospital and were subsequently diagnosed with HPP.

Results: Median diagnostic delay was 13 years. All patients had an ALP below reference range for age and gender, with lowest mean ALP of 16 IU/L. All but one patient were women with median age of 51 years. Most common presentation was peripheral joint pain in 85.7% of patients. This was due to early-onset CPPD (calcium pyrophosphate deposition disease) in 71.4% of patients, osteoarthritis in 50%, or bursitis in 50%. Axial pain was reported in 64% of patients due to osteoarthritis or spinal stenosis. Fifty percent of patients had a history of long bone pain. Fifty percent had previous fracture(s). A total of 28.6% of patients had psoriatic arthritis, of which 1 patient had spondyloarthropathy, and 4 patients also had enthesitis.

Conclusion: Patients with HPP can present to rheumatology with musculoskeletal pain, and if a persistently low ALP is confirmed, this may reduce the diagnostic delay of this rare disease. Similar to other rheumatologic patients, musculoskeletal pain in HPP was noted in peripheral joints and in the spine with almost a third of patients having psoriatic arthritis. Pain was also noted in the long bones, a feature consistent with metabolic bone disease. The diagnosis of HPP was also more likely in those patients with a personal or family history of dental disease or arthritis.

Keywords: Alkaline phosphatase; Hypophosphatasia; Musculoskeletal pain.

PubMed Disclaimer

Conflict of interest statement

None.

Similar articles

Cited by

References

    1. Kaur J, Nourabadi S, Chavez L, Sachemchi I. A concise review on hypophosphatasia with case report. Int J Med. 2016;4(2):39. doi: 10.14419/ijm.v4i2.6397. - DOI
    1. Conti F. Hypophosphatasia: clinical manifestation and burden of disease in adult patients. Clin Cases Miner Bone Metab. 2017;14(2):230. doi: 10.11138/ccmbm/2017.14.1.230. - DOI - PMC - PubMed
    1. Högler W, Langman C, Gomes Da Silva H, Fang S, Linglart A, Ozono K, et al. Diagnostic delay is common among patients with hypophosphatasia: initial findings from a longitudinal, prospective, global registry. BMC Musculoskelet Disord. 2019;20(1):1–9. doi: 10.1186/s12891-019-2420-8. - DOI - PMC - PubMed
    1. Schmidt T, Mussawy H, Rolvien T, Hawellek T, Hubert J, Rüther W, et al. Clinical, radiographic and biochemical characteristics of adult hypophosphatasia. Osteoporos Int. 2017;28(9):2653–2662. doi: 10.1007/s00198-017-4087-z. - DOI - PubMed
    1. Berkseth KE, Tebben PJ, Drake MT, Hefferan TE, Jewison DE, Wermers RA (2013) Clinical spectrum of hypophosphatasia diagnosed in adults. Bone 54(1):217. 10.1016/j.bone.2013.01.024 - PubMed

Substances